Clinical trial
A Prospective, Randomized, Double Arm, Controlled Study With Blinded Assessment to Evaluate the Safety and Effectiveness of the Tixel Fractional System in the Treatment of Periorbital Wrinkles in Comparison With Fractional Laser
NCT03454672 is registered in ClinicalTrials.gov with Novoxel Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, Double Arm, Controlled Study With Blinded Assessment to Evaluate the Safety and Effectiveness of the Tixel Fractional System in the Treatment of Periorbital Wrinkles in Comparison With Fractional Laser
- Lead sponsor
- Novoxel Ltd.
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- March 12, 2018
- Completion date
- September 4, 2020
- Enrollment
- 68 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
wrinkle